Bomet

Researchers are conducting a prospective observational study through the African Esophageal Cancer Consortium AfrECC to examine treatment outcomes for adults diagnosed with esophageal cancer. The study aims to describe various treatment methods used, assess patient experiences during and after treatment, and evaluate overall survival rates across participating sites. Participants in this study will receive standard treatments such as chemotherapy, radiation, chemo-radiotherapy, esophageal stenting, surgery, or supportive care as determined by their healthcare providers. The research involves collecting data from medical records and administering questionnaires to capture patient-reported outcomes related to these treatments over up to four years. During the study, participants will complete questionnaires, and their medical charts will be reviewed to gather information on treatment types and patient experiences. Researchers will measure the proportion of participants receiving different treatments, track changes in patient-reported symptom scores over time, and monitor overall survival. The study is planned to continue through June 2027, supporting long-term evaluation of treatment effects and patient quality of life.